Intervention not reported
Beta‐blockers + nitrates(1 RCT, 57 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
The intervention may leads to higher beta‐blockers + nitrates(1 RCT, 57 participants) (low certainty).
1 finding from 1 review
OR 3.41 [1.11, 11.28]
Studies not reported
Low
Intervention not reported
Beta‐blockers · people with liver cirrhosis and oesophageal varices with no history of bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Beta‐blockers + variceal band ligation(1 RCT, 140 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Beta‐blockers + sclerotherapy(1 RCT, 141 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes beta‐blockers + sclerotherapy(1 RCT, 141 participants) (very low certainty).
1 finding from 1 review
HR 0.92 [0.41, 2.08]
Studies not reported
Very low
Intervention not reported
Beta‐blockers + variceal band ligation(1 RCT, 173 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
The intervention may leads to lower beta‐blockers + variceal band ligation(1 RCT, 173 participants) (low certainty).
1 finding from 1 review
HR 0.21 [0.04, 0.71]
Studies not reported
Low
Intervention not reported
Beta‐blockers + variceal band ligation(2 RCTs, 313 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes beta‐blockers + variceal band ligation(2 RCTs, 313 participants) (very low certainty).
1 finding from 1 review
HR 1.11 [0.56, 2.19]
Studies not reported
Very low
Intervention not reported
Beta‐blockers + nitrates(2 RCTs, 203 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes beta‐blockers + nitrates(2 RCTs, 203 participants) (very low certainty).
1 finding from 1 review
HR 0.84 [0.44, 1.64]
Studies not reported
Very low
Intervention not reported
Beta‐blockers + sclerotherapy(2 RCTs, 167 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
The intervention may leads to higher beta‐blockers + sclerotherapy(2 RCTs, 167 participants) (low certainty).
1 finding from 1 review
HR 2.08 [1.03, 4.08]
Studies not reported
Low
Intervention not reported
Beta‐blockers plus Nitrates plus Variceal band ligation(No direct RCT) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention showed no clear difference in beta‐blockers plus Nitrates plus Variceal band ligation(No direct RCT) (low certainty).
1 finding from 1 review
HR 0.89 [0.4, 1.98]
Studies not reported
Low
Intervention not reported
Beta‐blockers plus Variceal band ligation(No direct RCT) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention showed no clear difference in beta‐blockers plus Variceal band ligation(No direct RCT) (low certainty).
1 finding from 1 review
HR 0.83 [0.22, 3.05]
Studies not reported
Low
Intervention not reported
Beta‐blockers(1 RCT; 91 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
It is very uncertain whether the intervention changes beta‐blockers(1 RCT; 91 participants) (very low certainty).
1 finding from 1 review
OR 0.47 [0.13, 1.53]
Studies not reported
Very low
Intervention not reported
Beta‐blockers plus Sclerotherapy(No direct RCT) · people with liver cirrhosis and previous oesophageal variceal bleeding
It is very uncertain whether the intervention changes beta‐blockers plus Sclerotherapy(No direct RCT) (very low certainty).
1 finding from 1 review
OR 1.29 [0.28, 5.7]
Studies not reported
Very low
Intervention not reported
Beta‐blockers(No direct RCT) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention may leads to higher beta‐blockers(No direct RCT) (low certainty).
1 finding from 1 review
OR 11.86 [1.16, 427.95]
Studies not reported
Low
Intervention not reported
Beta‐blockers plus Sclerotherapy(2 RCTs; 71 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention showed no clear difference in beta‐blockers plus Sclerotherapy(2 RCTs; 71 participants) (low certainty).
1 finding from 1 review
OR 1.46 [0.36, 6.06]
Studies not reported
Low
Intervention not reported
Beta‐blockers plus Sclerotherapy(2 RCTs; 128 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention showed no clear difference in beta‐blockers plus Sclerotherapy(2 RCTs; 128 participants) (low certainty).
1 finding from 1 review
Intervention not reported
Beta‐blockers plus Sclerotherapy(1 RCT; 40 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
It is very uncertain whether the intervention changes beta‐blockers plus Sclerotherapy(1 RCT; 40 participants) (very low certainty).
1 finding from 1 review
HR 1.26 [0.17, 10.1]
Studies not reported
Very low
Intervention not reported
Beta‐blockers(1 RCT; 28 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
It is very uncertain whether the intervention changes beta‐blockers(1 RCT; 28 participants) (very low certainty).
1 finding from 1 review
HR 0.46 [0, 43.25]
Studies not reported
Very low
Intervention not reported
Beta‐blockers(9 RCTs; 493 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention showed no clear difference in beta‐blockers(9 RCTs; 493 participants) (low certainty).
1 finding from 1 review
HR 0.88 [0.66, 1.18]
Studies not reported
Low
Intervention not reported
Beta‐blockers(6 RCTs; 420 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention probably leads to higher beta‐blockers(6 RCTs; 420 participants) (moderate certainty).
1 finding from 1 review
HR 1.62 [1.14, 2.38]
Studies not reported
Moderate
Intervention not reported
Beta‐blockers plus sclerotherapy(4 RCTs; 231 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention probably leads to lower beta‐blockers plus sclerotherapy(4 RCTs; 231 participants) (moderate certainty).
1 finding from 1 review
HR 0.6 [0.37, 0.95]
Studies not reported
Moderate